Research Portal

Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Research output: Contribution to journal › Article › peer-review

Standard Standard

Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. / Coombes, R.C.; Hall, E.; Gibson, L.J. et al.
In: New England Journal of Medicine, Vol. 350, No. 11, 11.03.2004, p. 1081-1092.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Coombes, RC, Hall, E, Gibson, LJ, Paridaens, R, Jassem, J, Delozier, T, Jones, SE, Alvarez, I, Bertelli, G, Ortmann, O, Coates, AS, Bajetta, E, Dodwell, D, Coleman, RE, Fallowfield, LJ, Mickiewicz, E, Andersen, J, Lonning, PE, Cocconi, G, Stewart, A, Stuart, NS, Snowdon, CF, Carpentieri, M, Massimini, G & Bliss, JM 2004, 'Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.', New England Journal of Medicine, vol. 350, no. 11, pp. 1081-1092. https://doi.org/10.1056/NEJMoa040331

APA

Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., Coates, A. S., Bajetta, E., Dodwell, D., Coleman, R. E., Fallowfield, L. J., Mickiewicz, E., Andersen, J., Lonning, P. E., Cocconi, G., ... Bliss, J. M. (2004). Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350(11), 1081-1092. https://doi.org/10.1056/NEJMoa040331

CBE

Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, et al. 2004. Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine. 350(11):1081-1092. https://doi.org/10.1056/NEJMoa040331

MLA

Coombes, R.C. et al. "Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.". New England Journal of Medicine. 2004, 350(11). 1081-1092. https://doi.org/10.1056/NEJMoa040331

VancouverVancouver

Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T et al. Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine. 2004 Mar 11;350(11):1081-1092. doi: 10.1056/NEJMoa040331

Author

Coombes, R.C. ; Hall, E. ; Gibson, L.J. et al. / Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. In: New England Journal of Medicine. 2004 ; Vol. 350, No. 11. pp. 1081-1092.

RIS

TY - JOUR

T1 - Randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

AU - Coombes, R.C.

AU - Hall, E.

AU - Gibson, L.J.

AU - Paridaens, R.

AU - Jassem, J.

AU - Delozier, T.

AU - Jones, S.E.

AU - Alvarez, I.

AU - Bertelli, G.

AU - Ortmann, O.

AU - Coates, A.S.

AU - Bajetta, E.

AU - Dodwell, D.

AU - Coleman, R.E.

AU - Fallowfield, L.J.

AU - Mickiewicz, E.

AU - Andersen, J.

AU - Lonning, P.E.

AU - Cocconi, G.

AU - Stewart, A.

AU - Stuart, N.S.

AU - Snowdon, C.F.

AU - Carpentieri, M.

AU - Massimini, G.

AU - Bliss, J.M.

PY - 2004/3/11

Y1 - 2004/3/11

KW - MEDICINE

KW - GENERAL & INTERNAL

U2 - 10.1056/NEJMoa040331

DO - 10.1056/NEJMoa040331

M3 - Article

VL - 350

SP - 1081

EP - 1092

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 11

ER -